Recent BioUtah News & Events

Published in the journal PREGNANCY, the PRIME Study demonstrates significant improvements in neonatal outcomes with early risk screening and targeted interventions.

Fluidx GPX Embolic Device Pivotal Trial Completes Enrollment

Dr. Mark Davis, discoverer of the first T-cell receptor genes and Stanford Professor, to advise the Company on immunological strategies for its novel cancer treatment platform.

Wasatch BioLabs Announces Co-Marketing Agreement With Agilent to Advance Native-Read Targeted Sequencing

As we look back at 2025, we’re thankful for the progress our team and partners helped drive this year.

The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)

2025 marked a year of significant progress of reached milestones and successes for Bloom Surgical

A microbiologist, Adam Barker, PhD, was ARUP’s chief scientific officer and director of Research and Development before being named chief operations officer—now adds Reference Business Unit president to his title.

The Australian patent represents the first patent granted for the Company’s new point-of-care testing platform.

Merit Medical’s Fred Lampropoulos Honored by Nasdaq

Perimeter Solutions Announces Agreement to Acquire MMT for $685 Million

Freyya Recognized at Transatlantic Angel Competition (TAAC8)

Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India

Collaboration expands Owlet’s national DME footprint, strengthens access for Medicaid and TRICARE families, and supports continued growth in prescription-backed revenue channel.

In-vitro studies confirmed strong uptake of cell-targeting nanoparticles by cancer cells and strong activation of Smart mRNAs inside cancer cells

Peel Therapeutics CEO Joshua Schiffman Presents at CureCRC Summit

Ratio Therapeutics has Successfully Dosed the First Cohort in its Phase 1/2 Study Evaluating a Novel FAP-Targeted Radiopharmaceutical in Patients with Late-Stage Aggressive Sarcomas

Investors Buy up Stocks in Biggest Follow-on Offering Day in Biotech History

Talent Ready Utah Calling for Innovator Input

TGA approval enables regional launch of Owlet’s clinically validated, award-winning infant health monitor; Owlet360™ subscription marks first international expansion of the Company’s recurring-revenue platform.

REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12 weeks of treatment (n=12).

New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin improvement.

FDA recommended biomarker analyses show statistically significant reductions in NfL and GFAP in participants treated with CNM-Au8.

Prestigious recognition validates Canary Speech’s leadership in healthcare-focused AI voice technology and its proven interoperability with the Microsoft Cloud

bioMérieux Celebrates New Regional Headquarters in Riyadh, Saudi Arabia

PolarityBio thanks the clinical trial sites and, most importantly, the participants, for making this milestone in DFU biologic therapy development possible

Milestone enables immediate production of SiN/PEEK custom devices

By Henry O’Connell, CEO and co-founder of Canary Speech   Vocal biomarker data has come a long way in a short amount of time. No longer relegated to the pages of science fiction, the power of the human voice to assist in diagnoses is established fact. Providers already possess technological platforms that make informed care […]

SALT LAKE CITY, UT (Business Wire) – Seek Labs, a biotechnology company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the publication of a peer-reviewed paper in Viruses (MDPI), revealing the first successful use of a CRISPR-based therapeutic to treat African Swine Fever Virus (ASFV) in pigs. The […]

This first-of-its-kind infant care collaboration for Owlet enables clinicians to access Owlet’s data through Locus Health’s platform, enhancing visibility, improving care continuity, and supporting families after hospital discharge. LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announces a partnership with Locus Health, a leader in […]

SALT LAKE CITY, November 19, 2025— With a deadline approaching on January 31, 2026, ARUP Laboratories has joined other clinical laboratories in advocating for passage of the federal Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, which would block looming cuts in payments for lab testing services, relieve labs of burdensome reporting, […]

The 2025 BioUtah Utah Life Sciences Summit (ULSS) took place November 12 at the Hilton Salt Lake City Center, featuring keynote speakers, awards, educational sessions, networking opportunities, and the signing of a Memorandum of Understanding (MOU) with the Korea Health Industry Development Institute. With 650 registrants, this year’s Summit was the biggest yet. Jefferson Moss, […]